IHH Healthcare's Q3 PATMI Comes In Flat
IHH Healthcare's Q3 PATMI Comes In Flat
The lower headline PATMI was primarily due to a high base last year, which recorded one-off gains of RM873.0 million from the sale of International Medical University. Excluding exceptional items, PATMI (ex EI) grew by 35%.
IHH Healthcare reported its third quarter financial performance recording revenue and EBITDA of RM5.6 billion and RM1.3 billion respectively. Across all key markets, IHH saw higher inpatient volumes as well as revenue intensity from taking on more complex cases. Excluding the effects of MFRS 129, revenue and EBITDA would have grown by 10% and 7% respectively.
IHH Healthcare公佈了其第三季度財務業績，收入和息稅折舊攤銷前利潤分別爲56令吉和13令吉。在所有主要市場中，IHH因受理更復雜的病例而獲得了更高的住院量和收入密集度。不包括MFRS 129的影響，收入和息稅折舊攤銷前利潤將分別增長10％和7％。
PATMI however was flat against last year at RM534 million versus RM532 million in Q3FY23. Excluding exceptional items, PATMI (ex EI) was up 43% on core operational growth.
但是，PATMI與去年持平，爲53400萬令吉，而 Q3FY23 爲53200萬令吉。不包括特殊項目，由於核心業務增長，PATMI（不包括EI）增長了43％。
As for year to date, revenue and EBITDA reported double-digit growth on sustained growth in patient volumes and revenue intensity across all markets, at 13% and 12% respectively.
截至今年迄今爲止，收入和息稅折舊攤銷前利潤報告了兩位數的增長，這要歸因於所有市場的患者數量和收入強度的持續增長，分別爲13％和12％。
The lower headline PATMI was primarily due to a high base last year, which recorded one-off gains of RM873.0 million from the sale of International Medical University. Excluding exceptional items, PATMI (ex EI) grew by 35%.
PATMI股價下跌的主要原因是去年基數較高，出售國際醫科大學一次性收益爲87300萬令吉。不包括特殊項目，PATMI（不包括EI）增長了35％。
Balance sheet remained strong: net cash generated from operating activities at RM3.1
billion; net gearing at healthy 0.24x.
資產負債表保持強勁：經營活動產生的淨現金爲3.1令吉
十億；淨資產負債率爲健康的0.24倍。
譯文內容由第三人軟體翻譯。
